54
Participants
Start Date
September 21, 2023
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
NMD670
Tablets
Placebo
Tablets
RECRUITING
Rare Disease Research - Raleigh-Durham, Hillsborough
WITHDRAWN
Rare Disease Center, Atlanta
RECRUITING
UF Fixel Institute for Neurological Diseases, Gainesville
RECRUITING
The Ohio State University Wexner Medical Center, Columbus
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Roy Blunt NextGen Precision Health Institute, Columbia
RECRUITING
University of Kansas Medical Center, Kansas City
RECRUITING
Neurology Rare Disease Center, Denton
RECRUITING
UCLA David Geffen School Of Medicine - Neurology, Los Angeles
RECRUITING
Stanford University Medical Center, Palo Alto
RECRUITING
UZ Leuven - Neurochirurgie Campus Gasthuisberg, Leuven
RECRUITING
CHR de la Citadelle - Neurologie, Liège
RECRUITING
Heritage Medical Research Clinic, Calgary
RECRUITING
Genge Partners Inc., Montreal
RECRUITING
Aarhus Universitetshospital, Neurologisk Afdeling, Aarhus
RECRUITING
Rigshospitalet - Neurologisk Afdeling, Copenhagen
RECRUITING
Charite - Campus Virchow-Klinikum (CVK), Berlin
RECRUITING
Universitätsklinikum Essen - Klinik Für Neurologie, Essen
RECRUITING
Istituto Giannina Gaslini, IRCCS, Genova
RECRUITING
Istituto Neurologico C. Besta, Fondazione IRCCS, Milan
RECRUITING
Ospedale Niguarda, ASST Grande Ospedale Metropolitano Niguarda, Milan
RECRUITING
Università degli studi di Pisa, Pisa
RECRUITING
PU A. Gemelli, Università Cattolica del Sacro Cuore, Roma
RECRUITING
AOU Città della Salute e della Scienza di Torino, Torino
RECRUITING
Universitair Medisch Centrum Utrecht, locatie Academisch Zie - Neurology, Utrecht
RECRUITING
Hospital Universitari Vall D Hebron, Barcelona
RECRUITING
H. Donostia, Donostia / San Sebastian
RECRUITING
Hospital Materno Infantil La Paz, Madrid
RECRUITING
Hospital Universitario y Politécnico La Fe, Valencia
Lead Sponsor
NMD Pharma A/S
INDUSTRY